Sartorius Aktiengesellscha Ownership
SARTF Stock | USD 182.98 9.77 5.07% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Sartorius |
Sartorius Pink Sheet Ownership Analysis
About 85.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 2.07. Sartorius Aktiengesellscha recorded earning per share (EPS) of 8.43. The entity last dividend was issued on the 28th of March 2022. The firm had 4:1 split on the 13th of June 2016. Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company was founded in 1870 and is headquartered in Gttingen, Germany. Sartorius operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 13832 people.The quote for Sartorius Aktiengesellschaft is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Sartorius Aktiengesellschaft contact Joachim Kreuzburg at 49 551 308 0 or learn more at https://www.sartorius.com.Currently Active Assets on Macroaxis
Other Information on Investing in Sartorius Pink Sheet
Sartorius Aktiengesellscha financial ratios help investors to determine whether Sartorius Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Aktiengesellscha security.